| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000226786.2 |
Ponatinib |
Lung squamous cell carcinoma |
0.014580232 |
Resistant |
| ENSG00000226786.2 |
Ponatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002853748 |
Sensitive |
| ENSG00000226786.2 |
Ponatinib |
Pancreatic adenocarcinoma |
0.044066187 |
Sensitive |
| ENSG00000226786.2 |
Ponatinib |
Skin cutaneous melanoma |
0.045286906 |
Resistant |
